Eledon Pharmaceuticals, Inc.
ELDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404281
No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Eledon Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 34 | 34 | 0 |
| Shares | 8.32M | 9.42M | +1.11M (+13.3%) |
| Value | $89.0M | $74.5M | −$14.4M (−16.2%) |
New holders (6)
Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Veritable, L.P. | 33,092 | $262.0K | 0.00% |
| State Street Corp | 32,935 | $261.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 643 | $5.00K | 0.00% |
| JPMorgan Chase & Co | 66 | $1.00K | 0.00% |
| Bank of America Corp | 141 | $1.00K | 0.00% |
| Simplex Trading, LLC | 35 | $0 | 0.00% |
Sold out (6)
Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| EcoR1 Capital, LLC | 1,115,721 | $11.9M |
| Citadel Advisors LLC | 25,062 | $268.0K |
| Susquehanna International Group, LLP | 22,247 | $238.0K |
| ExodusPoint Capital Management, LP | 17,773 | $190.0K |
| Citigroup Inc | 2,166 | $23.0K |
| Acadian Asset Management LLC | 1 | $0 |